Xiaohong Xie

1.5k total citations
90 papers, 999 citations indexed

About

Xiaohong Xie is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Xiaohong Xie has authored 90 papers receiving a total of 999 indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Pulmonary and Respiratory Medicine, 44 papers in Oncology and 28 papers in Epidemiology. Recurrent topics in Xiaohong Xie's work include Lung Cancer Treatments and Mutations (25 papers), Respiratory viral infections research (19 papers) and Cancer Immunotherapy and Biomarkers (19 papers). Xiaohong Xie is often cited by papers focused on Lung Cancer Treatments and Mutations (25 papers), Respiratory viral infections research (19 papers) and Cancer Immunotherapy and Biomarkers (19 papers). Xiaohong Xie collaborates with scholars based in China, United States and Japan. Xiaohong Xie's co-authors include Enmei Liu, Chengzhi Zhou, Yinyin Qin, Na Zang, Xinqing Lin, Zhanhong Xie, Ren Luo, Yu Deng, Simin Li and Lijia Wang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Journal of Virology.

In The Last Decade

Xiaohong Xie

79 papers receiving 992 citations

Peers

Xiaohong Xie
Xiaoli Jia China
Monika Laszkowska United States
Sheng‐Hao Lin Taiwan
Chia‐Jung Kuo Taiwan
Monjur Ahmed∥ United States
Yoshihiro Miyashita Japan
Min‐Jie Ju China
Yuwen Zhou China
Lilong Zhang China
Ju Hyun Kim South Korea
Xiaoli Jia China
Xiaohong Xie
Citations per year, relative to Xiaohong Xie Xiaohong Xie (= 1×) peers Xiaoli Jia

Countries citing papers authored by Xiaohong Xie

Since Specialization
Citations

This map shows the geographic impact of Xiaohong Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohong Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohong Xie more than expected).

Fields of papers citing papers by Xiaohong Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaohong Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohong Xie. The network helps show where Xiaohong Xie may publish in the future.

Co-authorship network of co-authors of Xiaohong Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaohong Xie. A scholar is included among the top collaborators of Xiaohong Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaohong Xie. Xiaohong Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Liu, Jiao, Leiqiong Gao, Yu Deng, et al.. (2024). p53 suppresses the inflammatory response following respiratory syncytial virus infection by inhibiting TLR2. Virology. 593. 110018–110018. 4 indexed citations
4.
Li, Ru, Haiyi Deng, Qingyang Li, et al.. (2024). The prognostic impact of severe grade immune checkpoint inhibitor related pneumonitis in non-small cell lung cancer patients. Frontiers in Oncology. 14. 1372532–1372532. 1 indexed citations
5.
He, Jun, et al.. (2024). Drug tolerant persister cell plasticity in cancer: a revolutionary strategy for more effective anticancer therapies. Signal Transduction and Targeted Therapy. 9(1). 209–209. 29 indexed citations
6.
7.
Du, Feng, Gengjia Chen, Yi Lin, et al.. (2024). Case report: Therapeutic response of front-line cadonilimab plus chemotherapy on patient with advanced lung adenocarcinoma harboring STK11 genetic aberration. Frontiers in Immunology. 15. 1485358–1485358. 1 indexed citations
8.
Lin, Xinqing, et al.. (2023). Successful management of Epstein‑Barr virus‑associated severe checkpoint inhibitor‑related pneumonitis: A case report. Experimental and Therapeutic Medicine. 25(5). 222–222. 1 indexed citations
9.
Wang, Fei, Xiaohong Xie, Ting Liu, et al.. (2023). A retrospective real‐world experience of immunotherapy in patients with extensive stage small‐cell lung cancer. Cancer Medicine. 12(14). 14881–14891. 11 indexed citations
10.
Deng, Haiyi, Xinqing Lin, Ziying Lin, et al.. (2023). A Risk-Scoring Model for Severe Checkpoint Inhibitor-Related Pneumonitis: A Case–Control Study. Clinical Drug Investigation. 43(5). 347–357. 7 indexed citations
11.
Zhang, Kening, Chengzhi Zhou, Xinqing Lin, et al.. (2022). Treatment response and safety of immunotherapy for advanced non-small cell lung cancer with comorbid chronic obstructive pulmonary disease: a retrospective cohort study. Translational Lung Cancer Research. 11(11). 2306–2317. 11 indexed citations
12.
Xie, Xiaohong, Jinzhuo Luo, Dan Zhu, et al.. (2022). HBeAg Is Indispensable for Inducing Liver Sinusoidal Endothelial Cell Activation by Hepatitis B Virus. Frontiers in Cellular and Infection Microbiology. 12. 797915–797915. 7 indexed citations
13.
Lin, Xinqing, Tingting Lü, Haiyi Deng, et al.. (2021). Serum neurofilament light chain or glial fibrillary acidic protein in the diagnosis and prognosis of brain metastases. Journal of Neurology. 269(2). 815–823. 10 indexed citations
14.
Xie, Xiaohong, Xinqing Lin, Ming Liu, et al.. (2020). A first case report of clinical response to targeted therapy in a patient with primary myoepithelial carcinoma of the lung harboring EGFR exon 19 deletion. Diagnostic Pathology. 15(1). 71–71. 3 indexed citations
15.
Wang, Fei, Xiaohong Xie, Mengmeng Song, et al.. (2020). Tumor immune microenvironment and mutational analysis of tracheal adenoid cystic carcinoma. Annals of Translational Medicine. 8(12). 750–750. 14 indexed citations
16.
Gao, Leiqiong, Jun Xie, Sisi Chen, et al.. (2019). Respiratory syncytial virus nonstructural protein 1 downregulates glucocorticoid receptor expression through miR-29a. Journal of Allergy and Clinical Immunology. 144(3). 854–857.e6. 6 indexed citations
17.
Li, Wei, et al.. (2017). An Interaction of LPS and RSV Infection in Augmenting the AHR and Airway Inflammation in Mice. Inflammation. 40(5). 1643–1653. 8 indexed citations
18.
Xie, Xiaohong, Yu Deng, Ren Luo, et al.. (2016). Association between secondary thrombocytosis and viral respiratory tract infections in children. Scientific Reports. 6(1). 22964–22964. 28 indexed citations
19.
Long, Xiaoru, Jun Xie, Wei Li, et al.. (2016). NK cells contribute to persistent airway inflammation and AHR during the later stage of RSV infection in mice. Medical Microbiology and Immunology. 205(5). 459–470. 21 indexed citations
20.
Long, Xiaoru, Simin Li, Jun Xie, et al.. (2015). MMP-12-mediated by SARM-TRIF signaling pathway contributes to IFN-γ-independent airway inflammation and AHR post RSV infection in nude mice. Respiratory Research. 16(1). 11–11. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoli Jia Breakdown of academic impact, for papers by Monika Laszkowska Breakdown of academic impact, for papers by Sheng‐Hao Lin Breakdown of academic impact, for papers by Chia‐Jung Kuo Breakdown of academic impact, for papers by Monjur Ahmed∥ Breakdown of academic impact, for papers by Yoshihiro Miyashita Breakdown of academic impact, for papers by Min‐Jie Ju Breakdown of academic impact, for papers by Yuwen Zhou Breakdown of academic impact, for papers by Lilong Zhang Breakdown of academic impact, for papers by Ju Hyun Kim
Rankless by CCL
2026